Global Scans · Genetics · Weekly Summary

• [New] Optical genome mapping could help uncover causes of recurrent pregnancy loss. EurekAlert!
• [New] The enrichment of SCZ-associated genes for the hippocampus could support the presence of clinically relevant targets for BCI/DBS therapies in the brain region area. PubMed Central (PMC)
• [New] Quantum-enabled personalized treatment plans will become available for complex conditions like cancer and rare genetic disorders by 2032. Futurist Speaker on AI Leadership, Future of Work, Futu
• [New] By 2025, 20% of healthcare organizations will have shifted from reactive sick care to proactive health based on genetic, behavioral, and social data. Futurist Speaker on AI Leadership, Future of Work, Futu
• [New] Genomic medicine will become mainstream within the decade. Futurist Speaker on AI Leadership, Future of Work, Futu
• [New] The convergence of AI, genomics, and connected devices is creating a perfect storm of innovation that will reshape medicine more in the next decade than it has in the past century. Futurist Speaker on AI Leadership, Future of Work, Futu
• [New] Researchers at the University of Duisburg-Essen investigated whether people could distinguish AI-generated mindfulness exercises from human-created ones and identified what factors influence acceptance of AI voices in meditation guidance. Mindful Leader
• [New] Research funding for women took a fresh step forward, with 65 grants launched to support postgraduate projects that drive education and income generation in Morocco. UAE Business Directory - Find Companies & Listings | UA
• [New] Researchers expect the next decade to bring even more detailed genetic maps of autism. Psychology Today
• [New] As most current BCI deployments do not consider neural data protection, BCIs toward interconnected devices generate security concerns which will increase in the near future, while the field of security oriented to BCIs is not yet mature, generating opportunities for attackers. PubMed Central (PMC)
• [New] CRISPR Therapeutics expects to initiate a clinical trial of CTX460 in mid-2026. Investing News Network (INN)
• [New] CRISPR Therapeutics is advancing a pipeline of in vivo gene editing candidates addressing major unmet needs in cardiovascular, metabolic and rare diseases using its proprietary, de-risked lipid nanoparticle delivery platform. Investing News Network (INN)
• [New] Africa's future in genomics will not be left to chance - it will be forged by courageous young scientists who dare to shape policies for justice and equitable health. Oncodaily - Oncology News, Insights, Stories

Last updated: 23 November 2025